Search Results
Found 1 results
510(k) Data Aggregation
(71 days)
This product is to be used in a diagnostic laboratory setting, by qualified laboratory technologists, for the quantitative determination of glucose in serum or plasma. It is intended for in vitro diagnostic use only. The determination of glucose in serum is most commonly performed for the diagnosis and treatment of diabetes mellitus.
Liquid Glucose (Hexokinase) Reagent Set
I am sorry, but the provided text does not contain the information required to describe the acceptance criteria and the study that proves the device meets those criteria. The document is a 510(k) clearance letter from the FDA for a Liquid Glucose (Hexokinase) Reagent Set, which primarily details the regulatory approval of the device based on substantial equivalence to a predicate device. It does not include details about specific performance studies, acceptance criteria, sample sizes, ground truth establishment, or expert qualifications.
Ask a specific question about this device
Page 1 of 1